AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8428715 — intervention group
Group type: EXPERIMENTAL
Intervention: Early antimicrobial therapy (groups 1, 2, and 3)
Number of subjects: 104
Study 8428715 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall survival
Number of subjects: 104
Study 3314469 — intervention group
Group type: EXPERIMENTAL
Intervention: High-glycemic-index (GI) breakfast foods
Number of subjects: 22
Study 3314469 — intervention group
Group type: COMPARATOR
Intervention: Low-glycemic-index (GI) breakfast foods
Number of subjects: 22
Study 3314469 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin adjustment based on carbohydrate amount
Number of subjects: 22
Study 29340888 — intervention group
Group type: EXPERIMENTAL
Intervention: Wet Cupping Therapy (WCT) for 10 min
Number of subjects: 57
Study 29340888 — intervention group
Group type: COMPARATOR
Intervention: Jiaji acupoint-acupuncture (JA) for 10 min
Number of subjects: 57
Study 26928677 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic salpingo‐oophorectomy
Number of subjects: 195
Study 26355881 — intervention group
Group type: EXPERIMENTAL
Intervention: Scaling and root planing plus minocycline microgranules (Test group=T)
Number of subjects: 26
Study 26355881 — intervention group
Group type: COMPARATOR
Intervention: Scaling and root planing alone (Control group=C)
Number of subjects: 26
Study 23331979 — intervention group
Group type: EXPERIMENTAL
Intervention: Fundamentals of Surgery Curriculum (FSC), 96 cases completed before internship orientation
Number of subjects: 20
Study 23331979 — intervention group
Group type: COMPARATOR
Intervention: Control group (no FSC accounts)
Number of subjects: 20
Study 21796252 — intervention group
Group type: EXPERIMENTAL
Intervention: Olmesartan plus Azelnidipine (16 mg daily)
Number of subjects: 50
Study 21796252 — intervention group
Group type: COMPARATOR
Intervention: Olmesartan plus Amlodipine (5 mg daily)
Number of subjects: 50
Study 19924353 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition education program coordinated by Nutrition Coordinators
Number of subjects: 352
Study 19924353 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 352
Study 16998093 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower body positive pressure (LBPP) of 40 mm Hg via antishock trousers
Number of subjects: 11
Study 16998093 — intervention group
Group type: COMPARATOR
Intervention: Control period
Number of subjects: 11
Study 15311657 — intervention group
Group type: EXPERIMENTAL
Intervention: Broad range of spatial frequencies in audiovisual speech perception task
Number of subjects: 0
Study 15311657 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-pass filtered images
Number of subjects: 0
Study 15311657 — intervention group
Group type: EXPERIMENTAL
Intervention: Spatial frequency band-pass filtered images
Number of subjects: 0
Study 15311657 — intervention group
Group type: COMPARATOR
Intervention: Viewing distance (not influenced)
Number of subjects: 0
Study 10951632 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisapride (0.2 mg/kg/dose every 8 hours for 14 days)
Number of subjects: 49
Study 10951632 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study 10951632 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisapride
Number of subjects: 49
Study 9028717 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil supplement (35 mg of 20:5 omega 3 + 22:6 omega 3.kg body weight‐1.day‐1)
Number of subjects: 28
Study 9028717 — intervention group
Group type: EXPERIMENTAL
Intervention: Linseed oil supplement (35 mg of 18:3 omega 3.kg body weight‐1.day‐1)
Number of subjects: 28
Study 9028717 — intervention group
Group type: COMPARATOR
Intervention: Olive oil supplement (placebo, 35 mg of 18:1.kg body weight‐1.day‐1)
Number of subjects: 28
Study 8281591 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam (0.2‐0.3 mg.kg‐1)
Number of subjects: 30
Study 8281591 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam (0.3‐0.4 mg.kg‐1)
Number of subjects: 30
Study 8281591 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunitrazepam (0.03‐0.04 mg.kg‐1)
Number of subjects: 30
Study 3046411 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous glucose-insulin-potassium infusion
Number of subjects: 20
Study 3046411 — intervention group
Group type: COMPARATOR
Intervention: Conventional subcutaneous insulin administration
Number of subjects: 20
Study 29661196 — intervention group
Group type: EXPERIMENTAL
Intervention: Women's Heart Health Programme (intervention)
Number of subjects: 100
Study 29661196 — intervention group
Group type: COMPARATOR
Intervention: Conventional sex-neutral cardiac programme (control)
Number of subjects: 100
Study 28478972 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab 300 mg once weekly plus topical corticosteroids
Number of subjects: 740
Study 28478972 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab 300 mg every 2 weeks plus topical corticosteroids
Number of subjects: 740
Study 28478972 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus topical corticosteroids
Number of subjects: 740
Study 26228567 — intervention group
Group type: EXPERIMENTAL
Intervention: Active rTMS (AG)
Number of subjects: 18
Study 26228567 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS (SG)
Number of subjects: 18
Study 23954314 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab, azathioprine, or both (specific dosages and duration not mentioned)
Number of subjects: 172
Study 23954314 — intervention group
Group type: EXPERIMENTAL
Intervention: Mucosal healing at week 26
Number of subjects: 172
Study 23954314 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic response at week 26
Number of subjects: 172
Study 23954314 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic response defined as a decrease from baseline in CDEIS of at least 50%
Number of subjects: 172
Study 21358435 — intervention group
Group type: EXPERIMENTAL
Intervention: Estimated time limits calculated at 90% MAP during the incremental test
Number of subjects: 25
Study 21358435 — intervention group
Group type: EXPERIMENTAL
Intervention: Estimated time limits calculated at 90% MAP during the randomized workloads test
Number of subjects: 25
Study 21358435 — intervention group
Group type: EXPERIMENTAL
Intervention: Measured ETL during the constant power output test
Number of subjects: 25
Study 21358435 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean difference between measured ETL values during the constant test for incremental test
Number of subjects: 25
Study 21358435 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean difference between measured ETL values during the constant test for randomized constant workloads test
Number of subjects: 25
Study 18492875 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual CT sonography guidance for radiofrequency ablation
Number of subjects: 101
Study 18492875 — intervention group
Group type: COMPARATOR
Intervention: B-mode sonographic guidance
Number of subjects: 101
Study 16859226 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline
Number of subjects: 10
Study 16859226 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 12564611 — intervention group
Group type: EXPERIMENTAL
Intervention: sibenadet (Viozan)
Number of subjects: 0
Study 12564611 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 0
Study 12564611 — intervention group
Group type: EXPERIMENTAL
Intervention: sibenadet or placebo (during exacerbation)
Number of subjects: 0
Study 10389044 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapy treatment
Number of subjects: 81
Study 10389044 — intervention group
Group type: COMPARATOR
Intervention: Non-physical activities intervention
Number of subjects: 81
Study 8912804 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking in the laboratory
Number of subjects: 10
Study 8912804 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking at home
Number of subjects: 10
Study 8912804 — intervention group
Group type: COMPARATOR
Intervention: Baseline HR values in both environments
Number of subjects: 10
Study 8912804 — intervention group
Group type: COMPARATOR
Intervention: Skin conductance (SC) data in both environments
Number of subjects: 10
Study 1853997 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician counseling and take-home pamphlets
Number of subjects: 339
Study 1853997 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 339
Study 6120142 — intervention group
Group type: EXPERIMENTAL
Intervention: Acebutolol (dosage not specified)
Number of subjects: 0
Study 6120142 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31621423 — intervention group
Group type: EXPERIMENTAL
Intervention: Adolescent only intervention group (A group)
Number of subjects: 791
Study 31621423 — intervention group
Group type: EXPERIMENTAL
Intervention: Adolescent and mother intervention group (A+M group)
Number of subjects: 791
Study 31621423 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 791
Study 31217004 — intervention group
Group type: EXPERIMENTAL
Intervention: Outreach practice facilitation intervention
Number of subjects: 36
Study 28095850 — intervention group
Group type: EXPERIMENTAL
Intervention: Training based on the mhGAP-IG (version 1.0) for GPs
Number of subjects: 0
Study 28095850 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 26378561 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose simvastatin and health education
Number of subjects: 655
Study 26378561 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 655
Study 23283370 — intervention group
Group type: EXPERIMENTAL
Intervention: Charnley (composite‐beam) prosthesis
Number of subjects: 120
Study 23283370 — intervention group
Group type: EXPERIMENTAL
Intervention: Exeter (double‐tapered) prosthesis
Number of subjects: 120
Study 23283370 — intervention group
Group type: EXPERIMENTAL
Intervention: C‐Stem (triple‐tapered) prosthesis
Number of subjects: 120
Study 23283370 — intervention group
Group type: COMPARATOR
Intervention: All prosthesis designs
Number of subjects: 120
Study 21341948 — intervention group
Group type: EXPERIMENTAL
Intervention: Semi-structured interviews
Number of subjects: 8
Study 19685108 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous adenosine 5'-triphosphate (ATP) infusion at a rate of 160 microg.kg(‐1).min(‐1) throughout surgery
Number of subjects: 30
Study 19685108 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous adenosine 5'-triphosphate (ATP) infusion
Number of subjects: 30
Study 19685108 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 30
Study 17334459 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane-remifentanil (Group DES-REM)
Number of subjects: 40
Study 17334459 — intervention group
Group type: COMPARATOR
Intervention: Total intravenous anesthesia (TIVA) (Group TIVA)
Number of subjects: 40
Study 15533144 — intervention group
Group type: EXPERIMENTAL
Intervention: Sofradex eardrops instilled perioperatively
Number of subjects: 61
Study 15533144 — intervention group
Group type: COMPARATOR
Intervention: Control (no drops)
Number of subjects: 61
Study 11475457 — intervention group
Group type: EXPERIMENTAL
Intervention: Arch index (Al)
Number of subjects: 272
Study 11475457 — intervention group
Group type: EXPERIMENTAL
Intervention: Vertical height of the navicular (NH)
Number of subjects: 272
Study 9626919 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% timolol ophthalmic solution
Number of subjects: 8
Study 9626919 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% timolol ophthalmic solution with oral nicardipine (40 mg)
Number of subjects: 8
Study 9626919 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% timolol ophthalmic solution with oral diltiazem (60 mg)
Number of subjects: 8
Study 9626919 — intervention group
Group type: COMPARATOR
Intervention: Oral nicardipine (40 mg)
Number of subjects: 8
Study 9626919 — intervention group
Group type: COMPARATOR
Intervention: Oral diltiazem (60 mg)
Number of subjects: 8
Study 7532742 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin, etoposide, and ifosfamide
Number of subjects: 0
Study 7532742 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin, etoposide, and bleomycin
Number of subjects: 0
Study 7532742 — intervention group
Group type: COMPARATOR
Intervention: Carboplatinum
Number of subjects: 0
Study 2894747 — intervention group
Group type: EXPERIMENTAL
Intervention: ICI 141.292 (100 mg once daily)
Number of subjects: 11
Study 2894747 — intervention group
Group type: EXPERIMENTAL
Intervention: ICI 141.292 (200 mg once daily)
Number of subjects: 11
Study 2894747 — intervention group
Group type: EXPERIMENTAL
Intervention: ICI 141.292 (300 mg once daily)
Number of subjects: 11
Study 2894747 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 31603868 — intervention group
Group type: EXPERIMENTAL
Intervention: Short education session about the risks of untreated hypertension
Number of subjects: 600
Study 31603868 — intervention group
Group type: COMPARATOR
Intervention: Control group (no education session)
Number of subjects: 600
Study 28109665 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose olanzapine (5mg/day) plus low-dose trifluoperazine (5mg/day)
Number of subjects: 0
Study 28109665 — intervention group
Group type: COMPARATOR
Intervention: Full-dose olanzapine (10mg/day)
Number of subjects: 0
Study 26812974 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary ultrasound guidance
Number of subjects: 100
Study 26812974 — intervention group
Group type: COMPARATOR
Intervention: Control group (bedside chest X-ray)
Number of subjects: 100
Study 23453367 — intervention group
Group type: EXPERIMENTAL
Intervention: Cast immobilization using Quickcast(®) (QC)
Number of subjects: 57
Study 23453367 — intervention group
Group type: COMPARATOR
Intervention: Removable, lever-type thermoplastic orthosis (LTTP)
Number of subjects: 57
Study 21203366 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP
Number of subjects: 174
Study 20467642 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate loading
Number of subjects: 60
Study 20467642 — intervention group
Group type: COMPARATOR
Intervention: Early loading
Number of subjects: 60
Study 17533704 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-etching system (Adper and Prompt, 3M‐ESPE)
Number of subjects: 62
Study 17533704 — intervention group
Group type: COMPARATOR
Intervention: Phosphate acid system
Number of subjects: 62
Study 14579790 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser needle stimulation
Number of subjects: 22
Study 14579790 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser needle acupuncture
Number of subjects: 22
Study 10861324 — intervention group
Group type: EXPERIMENTAL
Intervention: Observational studies
Number of subjects: 136
Study 10861324 — intervention group
Group type: COMPARATOR
Intervention: Randomized, controlled trials
Number of subjects: 136
Study 8987323 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 g of oral elemental calcium per day (n = 103)
Number of subjects: 201
Study 8987323 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 98)
Number of subjects: 201
Study 1639618 — intervention group
Group type: EXPERIMENTAL
Intervention: Levodopa, administered daily for 1 week
Number of subjects: 0
Study 1639618 — intervention group
Group type: COMPARATOR
Intervention: Previous study with a single dose of levodopa
Number of subjects: 0
Study 6712450 — intervention group
Group type: EXPERIMENTAL
Intervention: Active bilateral full‐range forearm flexion and extension movements (60 movements per minute) during the first and third minute of each tilt angle
Number of subjects: 12
Study 6712450 — intervention group
Group type: COMPARATOR
Intervention: No upper limb exercises
Number of subjects: 12
Study 30819827 — intervention group
Group type: EXPERIMENTAL
Intervention: MNC-developed ICIs
Number of subjects: 26
Study 30819827 — intervention group
Group type: EXPERIMENTAL
Intervention: Domestic-developed ICIs
Number of subjects: 26
Study 30144159 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete digital workflows (test)
Number of subjects: 20
Study 30144159 — intervention group
Group type: COMPARATOR
Intervention: Combined analog‐digital workflows (control)
Number of subjects: 20
Study 27424128 — intervention group
Group type: EXPERIMENTAL
Intervention: Omalizumab 300 mg
Number of subjects: 0
Study 23937297 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group received 2 individualized feedback sessions regarding safety and productivity-related issues in daily verbal exchanges.
Number of subjects: 7
Study 23937297 — intervention group
Group type: COMPARATOR
Intervention: Control group received no feedback.
Number of subjects: 7
Study 22710946 — intervention group
Group type: EXPERIMENTAL
Intervention: VaPro catheter
Number of subjects: 106
Study 22710946 — intervention group
Group type: COMPARATOR
Intervention: Conventional catheter
Number of subjects: 106
Study 20013018 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional end-to-end anastomosis using a linear stapler
Number of subjects: 119
Study 20013018 — intervention group
Group type: COMPARATOR
Intervention: Conventional ileostomy takedown
Number of subjects: 119
Study 18686768 — intervention group
Group type: EXPERIMENTAL
Intervention: Root debridement with Gracey curettes and root brushing with 40% tetracycline gel
Number of subjects: 20
Study 18686768 — intervention group
Group type: COMPARATOR
Intervention: Root debridement with Gracey curettes and root brushing with saline solution
Number of subjects: 20
Study 16414910 — intervention group
Group type: EXPERIMENTAL
Intervention: H2460 dressing
Number of subjects: 10
Study 16414910 — intervention group
Group type: COMPARATOR
Intervention: Flexzan dressing
Number of subjects: 10
Study 12560019 — intervention group
Group type: EXPERIMENTAL
Intervention: Engaged with the intervention (defined as finding it useful and interesting)
Number of subjects: 8352
Study 12560019 — intervention group
Group type: EXPERIMENTAL
Intervention: Disengaged from the intervention (not finding it useful or interesting)
Number of subjects: 8352
Study 9792282 — intervention group
Group type: EXPERIMENTAL
Intervention: Major surgery
Number of subjects: 23
Study 9792282 — intervention group
Group type: COMPARATOR
Intervention: Non-operated control group
Number of subjects: 23
Study 7836084 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative radiation therapy and CMF chemotherapy simultaneously
Number of subjects: 138
Study 7836084 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 138
Study 7836084 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous radiation therapy and chemotherapy
Number of subjects: 138
Study 7836084 — intervention group
Group type: COMPARATOR
Intervention: Radiation therapy alone
Number of subjects: 138
Study 2403061 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous maltose infusion
Number of subjects: 0
Study 2403061 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous glucose infusion
Number of subjects: 0
Study 319326 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical training (6-week period)
Number of subjects: 0
Study 30860417 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-myofascial release with movement of the pectoralis minor
Number of subjects: 21
Study 30860417 — intervention group
Group type: COMPARATOR
Intervention: Placebo (minimal pressure applied to the xiphoid process)
Number of subjects: 21
Study 29902020 — intervention group
Group type: EXPERIMENTAL
Intervention: Still Climbin' intervention
Number of subjects: 64
Study 29902020 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 64
Study 29122260 — intervention group
Group type: EXPERIMENTAL
Intervention: Olfactory mental imagery (experimental group)
Number of subjects: 80
Study 29122260 — intervention group
Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 80
Study 26337603 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical marijuana
Number of subjects: 868
Study 26337603 — intervention group
Group type: COMPARATOR
Intervention: Recreational marijuana
Number of subjects: 868
Study 24072234 — intervention group
Group type: EXPERIMENTAL
Intervention: B-ultrasound-guided IHP with 48 °C distilled water (DW)
Number of subjects: 23
Study 24072234 — intervention group
Group type: COMPARATOR
Intervention: B-ultrasound-guided IHP with 45 °C physiological saline solution and cisplatin (PSS-C)
Number of subjects: 23
Study 21138775 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity transcranial magnetic stimulation (TMS) during voluntary breathing
Number of subjects: 10
Study 21138775 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity transcranial magnetic stimulation (TMS) during static inspiratory effort
Number of subjects: 10
Study 21138775 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity transcranial magnetic stimulation (TMS) during involuntary ventilation
Number of subjects: 10
Study 18500156 — intervention group
Group type: EXPERIMENTAL
Intervention: elmex SENSITIVE toothbrush
Number of subjects: 107
Study 18500156 — intervention group
Group type: COMPARATOR
Intervention: ADA reference brush
Number of subjects: 107
Study 16594930 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin K2 (menatetrenone) 45 mg and calcium carbonate 1500 mg per day
Number of subjects: 63
Study 16594930 — intervention group
Group type: COMPARATOR
Intervention: Placebo and calcium carbonate 1500 mg per day
Number of subjects: 63
Study 12690583 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic therapy (3 times weekly for 6 weeks)
Number of subjects: 20
Study 12690583 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive‐resistive robotic therapy
Number of subjects: 20
Study 12690583 — intervention group
Group type: COMPARATOR
Intervention: Sensorimotor robotic therapy
Number of subjects: 20
Study 11189800 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmented care
Number of subjects: 619
Study 11189800 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 619
Study 11189800 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 619
Study 9661615 — intervention group
Group type: EXPERIMENTAL
Intervention: Deslorelin at a dose of 1 microgram/kg.day
Number of subjects: 20
Study 9661615 — intervention group
Group type: EXPERIMENTAL
Intervention: Deslorelin at a dose of 2 micrograms/kg.day
Number of subjects: 20
Study 9661615 — intervention group
Group type: EXPERIMENTAL
Intervention: Deslorelin at a dose of 4 micrograms/kg.day
Number of subjects: 20
Study 8001357 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccine for the prevention of haemophilus influenzae type b
Number of subjects: 0